Cite
HARVARD Citation
Papini, F. et al. (2021). Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?. Critical reviews in oncology/hematology. p. . [Online].